StreetInsider.com News Articles

Form 4 Quanterix Corp For: Jun 15 Filed by: Miller Michael Francis

Tue, 16 Jun 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260616/26654051.html

Form 4 Quanterix Corp For: Jun 15 Filed by: Miller Michael Francis

Tue, 16 Jun 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260616/26654051.html

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Tue, 16 Jun 2026 16:01:00 -0400

BILLERICA, Mass.--(BUSINESS WIRE)-- Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that on June 15, 2026, inducement grants (the “Inducement Grants”) were made to three employees in connection with the commencement of their employment. The Inducement Grants consisted of 336,804 restricted stock units (“RSUs”) representing 336,804 shares of Quanterix common stock.

The RSUs vest in four equal installments on the first four anniversaries of the grant date, subject to the applicable individual’s continued employment with the Company or one of its subsidiaries through the

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Tue, 16 Jun 2026 16:01:00 -0400

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Tue, 16 Jun 2026 16:01:00 -0400

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Tue, 16 Jun 2026 16:01:00 -0400

Form 4 Quanterix Corp For: May 12 Filed by: Meadows Benjamin

Fri, 12 Jun 2026 17:32:00 -0400

si-local-file:///var/storage/secattach/20260612/26642248.html

Form 4 Quanterix Corp For: May 12 Filed by: Meadows Benjamin

Fri, 12 Jun 2026 17:32:00 -0400

si-local-file:///var/storage/secattach/20260612/26642248.html

Form 3 Quanterix Corp For: Feb 23 Filed by: Meadows Benjamin

Fri, 12 Jun 2026 17:30:00 -0400

si-local-file:///var/storage/secattach/20260612/26642239.html

Form 3 Quanterix Corp For: Feb 23 Filed by: Meadows Benjamin

Fri, 12 Jun 2026 17:30:00 -0400

si-local-file:///var/storage/secattach/20260612/26642239.html

Form 8-K Quanterix Corp For: Jun 09

Wed, 10 Jun 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260610/26630132.html

Form 8-K Quanterix Corp For: Jun 09

Wed, 10 Jun 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260610/26630132.html

Form 8-K Quanterix Corp For: Jun 09

Tue, 09 Jun 2026 08:07:00 -0400

si-local-file:///var/storage/secattach/20260609/26620692.html

Form 8-K Quanterix Corp For: Jun 09

Tue, 09 Jun 2026 08:07:00 -0400

si-local-file:///var/storage/secattach/20260609/26620692.html

Quanterix names Jason Faessler as chief financial officer

Tue, 09 Jun 2026 08:03:08 -0400

Quanterix Corporation (NASDAQ: QTRX) announced the appointment of Jason Faessler as chief financial officer, effective June 22, according to a company statement.

Faessler joins the biomarker detection company from Bruker Corporation, where he served as senior vice president leading global financial planning and analysis and the Americas finance organization. His responsibilities included strategic planning, operational finance, and capital decision-making.

Prior to Bruker, Faessler held senior finance leadership positions at PAREXEL, where he led the company's early- and late-phase clinical divisions. He also held senior financial management roles at EMC, now Dell, and Harvard Business Publishing.

"His extensive track record within life science organizations

Quanterix names Jason Faessler as chief financial officer

Tue, 09 Jun 2026 08:03:08 -0400

Quanterix Corporation (NASDAQ: QTRX) announced the appointment of Jason Faessler as chief financial officer, effective June 22, according to a company statement.

"His extensive track record within life science organizations

Quanterix Announces Appointment of Jason Faessler as Chief Financial Officer

Tue, 09 Jun 2026 08:03:00 -0400

BILLERICA, Mass.--(BUSINESS WIRE)-- Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced the appointment of Jason Faessler as the Company’s new Chief Financial Officer, effective June 22. Faessler brings extensive finance leadership experience and expertise in managing complex organizations in the life science tools industry, positioning him to play a pivotal role in executing Quanterix’s strategic growth plans in the coming years.

“We are thrilled to welcome Jason to the Quanterix leadership team,” said Everett Cunningham, Chief Executive Officer of Quanterix. “His extensive track record within life science organizations

Quanterix Announces Appointment of Jason Faessler as Chief Financial Officer

Tue, 09 Jun 2026 08:03:00 -0400

“We are thrilled to welcome Jason to the Quanterix leadership team,” said Everett Cunningham, Chief Executive Officer of Quanterix. “His extensive track record within life science organizations

Quanterix Announces Appointment of Jason Faessler as Chief Financial Officer

Tue, 09 Jun 2026 08:03:00 -0400

“We are thrilled to welcome Jason to the Quanterix leadership team,” said Everett Cunningham, Chief Executive Officer of Quanterix. “His extensive track record within life science organizations

Quanterix Announces Appointment of Jason Faessler as Chief Financial Officer

Tue, 09 Jun 2026 08:03:00 -0400

“We are thrilled to welcome Jason to the Quanterix leadership team,” said Everett Cunningham, Chief Executive Officer of Quanterix. “His extensive track record within life science organizations

Quanterix names Geoff Albrecht as diagnostics business head